BioSpace News Archive

Sema4 today announced the appointment of Andrew Kasarskis , PhD, to the newly established role of Chief Data Officer (CDO).

Appili Therapeutics Inc. has added several clinical research sites in Mexico and Brazil to its Phase 3 clinical trial evaluating Avigan®/Reeqonus™ (favipiravir) as a potential oral therapy for patients with mild-to-moderate COVID-19.

Psyence Group Inc., a public life science biotechnology company pioneering the use of natural psychedelics, is pleased to announce that through its wholly owned Jamaican subsidiary, Psyence Jamaica Limited, it has entered into a multi-year agreement with the Jamaican government’s Scientific Research Council.